ATE269065T1 - Behandlung von verdauungsstörungen - Google Patents

Behandlung von verdauungsstörungen

Info

Publication number
ATE269065T1
ATE269065T1 AT99948969T AT99948969T ATE269065T1 AT E269065 T1 ATE269065 T1 AT E269065T1 AT 99948969 T AT99948969 T AT 99948969T AT 99948969 T AT99948969 T AT 99948969T AT E269065 T1 ATE269065 T1 AT E269065T1
Authority
AT
Austria
Prior art keywords
dyspepsia
medicament
treatment
xanthophylls
prophylactic
Prior art date
Application number
AT99948969T
Other languages
English (en)
Inventor
Ake Lignell
Original Assignee
Astareal Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astareal Ab filed Critical Astareal Ab
Application granted granted Critical
Publication of ATE269065T1 publication Critical patent/ATE269065T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99948969T 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen ATE269065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
PCT/EP1999/007551 WO2000023064A1 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia

Publications (1)

Publication Number Publication Date
ATE269065T1 true ATE269065T1 (de) 2004-07-15

Family

ID=20412979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99948969T ATE269065T1 (de) 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen

Country Status (11)

Country Link
US (1) US6923967B1 (de)
EP (1) EP1121106B1 (de)
JP (1) JP2002527472A (de)
AT (1) ATE269065T1 (de)
AU (1) AU763995B2 (de)
CA (1) CA2346647C (de)
DE (1) DE69918152T2 (de)
ES (1) ES2222732T3 (de)
NO (1) NO330158B1 (de)
SE (1) SE524337C2 (de)
WO (1) WO2000023064A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070128310A1 (en) 2003-12-19 2007-06-07 Meni-One Co., Ltd. Astaxanthin-containing pet foods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
JPWO2014208511A1 (ja) * 2013-06-27 2017-02-23 学校法人同志社 アスタキサンチン含有腸内フローラ改善組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57105145A (en) * 1980-12-23 1982-06-30 Koichi Tanaka Feed additive
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IL110139A0 (en) 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
WO1996023489A2 (de) * 1995-02-03 1996-08-08 Basf Aktiengesellschaft Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE522246C2 (sv) * 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Also Published As

Publication number Publication date
CA2346647A1 (en) 2000-04-27
EP1121106A1 (de) 2001-08-08
NO20011667L (no) 2001-04-03
AU6201699A (en) 2000-05-08
SE524337C2 (sv) 2004-07-27
AU763995B2 (en) 2003-08-07
EP1121106B1 (de) 2004-06-16
WO2000023064A1 (en) 2000-04-27
US6923967B1 (en) 2005-08-02
DE69918152T2 (de) 2005-07-07
SE9803541D0 (sv) 1998-10-16
NO20011667D0 (no) 2001-04-03
NO330158B1 (no) 2011-02-28
ES2222732T3 (es) 2005-02-01
SE9803541L (sv) 2000-04-17
DE69918152D1 (de) 2004-07-22
CA2346647C (en) 2003-03-11
JP2002527472A (ja) 2002-08-27

Similar Documents

Publication Publication Date Title
ATE243030T1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
US4442125A (en) Process for detaching or preventing attachment of microorganisms to a surface
US6258855B1 (en) Method of retarding and ameliorating carpal tunnel syndrome
JP4927723B2 (ja) 老化の皮膚徴候を治療するのに適した組成物
US8309081B2 (en) Composition and method for treatment of bruising
RO117590B1 (ro) Compozitie pentru tratamentul unei degenerari, boli colagenice sau inflamatorii
SE454566B (sv) Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
US5531992A (en) Low molecular weight vegetable composition
DE69918152D1 (de) Behandlung von verdauungsstörungen
US20070264311A1 (en) Cysteine Protease from Ginger (Zingiber) as a Food Improver and Anti-Inflammatory
SE9704590L (sv) Sätt att öka produktionen av och förbättra kvaliteten hos sperma
EP1399172A1 (de) Pharmazeutische und nährungsprodukte auf basis von seehundsöl, verfahren zu ihrer herstellung; ihre verwendung als präventive oder therapeutische mittel
Fuller et al. Aortic connective tissue changes in miniature pigs fed a lipid-rich diet
ATE253357T1 (de) Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
CA2405479A1 (en) Method of inhibiting the expression of inflammatory cytokines and chemokines
HUP9802314A2 (hu) Zeaxantin tiszta 3R-3'R sztereoizomerje makuláris degeneráció emberben való kezelésére
US5576005A (en) Effectiveness of wart removal by compositions including propolis
KR20150011763A (ko) 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
RU94030216A (ru) Противовоспалительная общеукрепляющая лекарственная смесь из натуральных и растительных продуктов
DE10103271A1 (de) Pharmazeutische Formulierungen zur Erweichung von Bindegewebe, insbesondere zur Formkorrektur von Bindegewebe und Bindegewebestrukturen
BRPI0706837A2 (pt) uso de compostos epoxidados
JP2008007481A (ja) 血管新生阻害剤
CN118697812A (zh) 一种使用酶解工艺制备的改善心脑血管功能、抗肿瘤、提高免疫海洋生物制剂
RU94022334A (ru) Способ лечения и профилактики инвазионных заболеваний

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties